Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Yasuaki Okuda »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Yassir A. Mohamed < Yasuaki Okuda < Yasuchika Aoki  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000022 (2006) Yasuaki Okuda [Japon] ; Kiyoshi TakasugiSuccessful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis.
000171 (2008) Yasuaki Okuda [Japon]Review of tocilizumab in the treatment of rheumatoid arthritis.
000294 (2011) Dai Kishida [Japon] ; Yasuaki Okuda ; Makoto Onishi ; Masashi Takebayashi ; Kenichiro Matoba ; Kazuo Jouyama ; Akihiro Yamada ; Naoya Sawada ; Sho Mokuda ; Kiyoshi TakasugiSuccessful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis.
000861 (2013) Sho Mokuda [Japon] ; Yosuke Murata ; Naoya Sawada ; Kenichiro Matoba ; Akihiro Yamada ; Makoto Onishi ; Yasuaki Okuda ; Kazuo Jouyama ; Eiji Sugiyama ; Kiyoshi TakasugiTocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.
000958 (2014) Yasuaki Okuda [Japon] ; Makoto Ohnishi ; Kenichiro Matoba ; Kazuo Jouyama ; Akihiro Yamada ; Naoya Sawada ; Sho Mokuda ; Yousuke Murata ; Kiyoshi TakasugiComparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases.
001B66 (2018) Yasuaki Okuda [Japon] ; Toshiyuki Yamada [Japon] ; Mitsuharu Ueda [Japon] ; Yukio Ando [Japon]First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan.
001B72 (2019) Yasuaki Okuda [Japon]AA amyloidosis - Benefits and prospects of IL-6 inhibitors.
002192 (????) Yasuaki Okuda [Japon] ; Toshiyuki Yamada [Japon] ; Mitsuharu Ueda [Japon] ; Yukio Ando [Japon]Nationwide survey of 199 patients with reactive amyloid a amyloidosis in Japan.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Yasuaki Okuda" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Yasuaki Okuda" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Yasuaki Okuda
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021